Although COVID-19 presents primarily as a lower respiratory tract infection transmitted via air
droplets, increasing data suggest multiorgan involvement in patients that are infected. This …

The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or
new symptoms in a subset of patients who have recovered from acute illness. Globally, the …

Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …

Patients with multiple myeloma (MM) are at an increased risk for infection because of their
immunocompromised state, old age, and comorbidities. 1 Coronavirus disease 2019 (COVID-…

Coronavirus disease 19 (COVID‐19) is considered a multisystemic disease. Several studies
have reported persistent symptoms or late‐onset complications after acute COVID‐19, …

Clinical trials with carfilzomib have indicated a low but reproducible incidence of cardiovascular
and renal toxicities. Among 60 consecutive myeloma patients treated with carfilzomib-…

Simple Summary The urgency of the COVID-19 pandemic has led to accelerated vaccine
development within less than a year. Emerging data suggest that the ability of patients with …

Immunocompromised patients with hematologic malignancies are more susceptible to
COVID-19 and at higher risk of severe complications and worse outcomes compared with the …

Cold antibody-mediated autoimmune hemolytic anemia (cAIHA) is a rare disease, usually
related to an underlying indolent clonal B-cell lymphoproliferative disorder. Jalink and …